Moreover, analysis of immune landscape suggested that the tumor microenvironment (TME) and tumor-infiltrating lymphocytes (macrophages M0, monocytes, NK cell activation, T cell CD4+ naive and Tregs) were significantly different between the high-risk group and low-risk group. The gene discussed is CD4; the disease is neoplasm.